Age at Diagnosis and the Utility of Prognostic Testing in Patients With Chronic Lymphocytic Leukemia
Age at Diagnosis and the Utility of Prognostic Testing in Patients With Chronic Lymphocytic Leukemia
复制标题
DOI：
10.1002/cncr.25292
复制
发表时间：
2010-10-15
期刊：
影响因子：
6.2
通讯作者：
Call, Timothy G.
中科院分区：
文献类型：
--
作者：
Shanafelt, Tait D.;Rabe, Kari G.;Call, Timothy G.
BACKGROUND: A study was undertaken to analyze the survival of chronic lymphocytic leukemia (CLL) patients relative to age-matched individuals in the general population and determine the age-stratified utility of prognostic testing. METHODS: All 2487 patients diagnosed with CLL between January 1995 and June 2008 and cared for in the Mayo Clinic Division of Hematology were categorized by age at diagnosis and evaluated for differences in clinical characteristics, time to first treatment, and overall survival (OS). RESULTS: Among Rai stage 0 patients, survival was shorter than the age-matched general population for patients aged
